Kashif Rashid

General Counsel, NEVRO CORP.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Aug 10, 2026Granted 181,818 shares of Sight Sciences, Inc.3
  • Apr 3, 2025Returned to company 477,738 shares of NEVRO CORP4
  • Mar 20, 2025Shares withheld for tax 611 shares at $5.78 of NEVRO CORP5
  • Mar 20, 2025Granted 1,136 shares of NEVRO CORP5
  • Mar 7, 2025Shares withheld for tax 15,136 shares at $5.77 of NEVRO CORP6
  • Mar 7, 2025Shares withheld for tax 1,758 shares at $5.77 of NEVRO CORP6
  • Mar 2, 2025Shares withheld for tax 944 shares at $5.72 of NEVRO CORP7
  • Feb 28, 2025Shares withheld for tax 825 shares at $5.72 of NEVRO CORP7
  • Feb 28, 2025Shares withheld for tax 392 shares at $5.72 of NEVRO CORP7
  • Feb 28, 2025Granted 742 shares of NEVRO CORP7
  • Jan 4, 2025Shares withheld for tax 527 shares at $3.71 of NEVRO CORP8
  • Dec 7, 2024Shares withheld for tax 1,759 shares at $4.19 of NEVRO CORP9
  • Nov 28, 2024Shares withheld for tax 816 shares at $4.58 of NEVRO CORP10
  • Oct 4, 2024Shares withheld for tax 479 shares at $4.97 of NEVRO CORP11
  • Sep 7, 2024Shares withheld for tax 1,759 shares at $5.18 of NEVRO CORP12
  • Aug 28, 2024Shares withheld for tax 817 shares at $5.76 of NEVRO CORP13
  • Jul 4, 2024Shares withheld for tax 479 shares at $8.38 of NEVRO CORP14
  • Jun 7, 2024Shares withheld for tax 1,759 shares at $9.27 of NEVRO CORP15
  • May 28, 2024Shares withheld for tax 817 shares at $9.52 of NEVRO CORP16
  • Apr 4, 2024Shares withheld for tax 479 shares at $13.21 of NEVRO CORP17
  • Mar 7, 2024Shares withheld for tax 7,045 shares at $15.32 of NEVRO CORP18
  • Mar 7, 2024Granted 84,326 shares of NEVRO CORP18
  • Mar 4, 2024Shares withheld for tax 425 shares at $14.51 of NEVRO CORP19
  • Mar 4, 2024Granted 743 shares of NEVRO CORP19
  • Mar 2, 2024Shares withheld for tax 1,790 shares at $14.22 of NEVRO CORP20